Company intelligence / Profile preview

Medipredict

Ownership: Private
Development stage: Commercial

Overview

Medipredict offers comprehensive personalized health evaluations using advanced diagnostics—genomic sequencing, metabolomic profiling, microbiome analysis—and integrates these with medical history to predict disease risks and provide early detection. The company focuses on preventive healthcare and longevity through tailored recommendations. No clinical trial results as it does not develop therapeutics.

Therapeutic areas: Other
Modalities: Non-pharmacological therapy (personalized preventive health)Genomics-based analysis (Whole-genome sequencing)Metabolomics-based analysisMicrobiome-based analysisMedical imaging/diagnostics (Instrumental and in-vivo diagnostics)Lifestyle intervention/dietetics guidance
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Medipredict.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medipredict.

Explore the full profile